Postmenopausal bleeding

2013 ◽  
Vol 6 (11) ◽  
pp. 709-716
Author(s):  
Rebecca Pugh ◽  
Anna Humphries
Keyword(s):  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Secondary Care ◽  
Hormone Replacement ◽  
Postmenopausal Bleeding ◽  
Urgent Referral ◽  
Underlying Malignancy ◽  
Unscheduled Bleeding ◽  
Careful History

Postmenopausal bleeding (PMB) is one of the most common reasons for referral to gynaecology services. This is due to the concern of possible underlying malignancy, as approximately 10% of women with PMB will have endometrial cancer. With growing use of hormone replacement therapy there is increased uncertainty as to what constitutes unscheduled bleeding and careful history and examination is required. Although benign conditions represent the most frequent cause of PMB, all women will require urgent referral and investigation in secondary care.

MENOPAUSAL HORMONOTHERAPY IN ONCOGYNECOLOGIC PATIENTS

2017 ◽  
Vol 63 (6) ◽  
pp. 843-854
Author(s):  
Olga Novikova ◽  
Yelena Ulrikh ◽  
V. Nosov ◽  
A. Charkhifalakyan
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Hormone Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Menopausal Hormone Therapy ◽  
Oncological Safety

There is presented the review of domestic and foreign references on the conserved oncological safety of the use of menopausal hormone therapy after treatment for endometrial cancer, cervical cancer, borderline and malignant ovarian tumors, various variants of sarcomas of the uterus, vulva and vaginal cancer. To the opinion of the authors the refusal to prescribe menopausal hormone therapy to patients with oncogynecologic diseases in the anamnesis is usually not justified, the category of patients, to whom hormone replacement therapy is contraindicated, is well described and mentioned in the text. In other cases sex hormones can be used to treat menopausal symptoms and improve the quality of life of patients.

Hysteroscopy in women with abnormal uterine bleeding on hormone replacement therapy: a comparison with postmenopausal bleeding

1996 ◽  
Vol 65 (6) ◽  
pp. 1145-1150 ◽  
Author(s):  
Fritz Nagele ◽  
Hugh O’Connor ◽  
Thomas F. Baskett ◽  
Anthony Davies ◽  
Hossam Mohammed ◽  
...  
Keyword(s):  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Abnormal Uterine Bleeding ◽  
Uterine Bleeding ◽  
Postmenopausal Bleeding

Endometrial cancer and hormone-replacement therapy

The Lancet ◽  
2005 ◽  
Vol 366 (9481) ◽  
pp. 201-202 ◽  
Author(s):  
Inka Wiegratz ◽  
Herbert Kuhl
Keyword(s):  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Replacement Therapy ◽  
Hormone Replacement

scholarly journals Estrogen Sulfation Genes, Hormone Replacement Therapy, and Endometrial Cancer Risk

2006 ◽  
Vol 98 (18) ◽  
pp. 1311-1320 ◽  
Author(s):  
Timothy R. Rebbeck ◽  
Andrea B. Troxel ◽  
Yiting Wang ◽  
Amy H. Walker ◽  
Saarene Panossian ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Hormone Replacement Therapy ◽  
Cancer Risk ◽  
Replacement Therapy ◽  
Hormone Replacement ◽  
Endometrial Cancer Risk
Sign in / Sign up

Export Citation Format

Share Document